Dr. Alexis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box 679b
Rochester, NY 14642Phone+1 585-276-9761Fax+1 585-427-8718
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1995 - 1998
- Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1995
- Harvard Medical SchoolClass of 1992
Certifications & Licensure
- NY State Medical License 1995 - 2025
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsAssociation of Psychosocial Risk Factors With Quality of Life and Readmissions 1 Year After LVAD Implantation.Jeffrey Wang, Alexis K Okoh, Yuxuan Chen, Rebecca S Steinberg, Apoorva Gangavelli
Journal of Cardiac Failure. 2024-04-15 - 1 citationsSex Differences in Myocardial Histology, Gene Expression, and Myocardial Recovery in Recent-Onset Cardiomyopathy.Agnes Koczo, Anjali Rao, Randall C Starling, Leslie T Cooper, G William Dec
JACC. Heart Failure. 2023-12-01 - Less Invasive Left Ventricular Assist Device Implantation Is Safe and Feasible in Patients With Smaller Body Surface Area.Madelaine Hack, Katherine L Wood, Milica Bjelic, Frane Paic, Himabindu Vidula
Innovations. 2023-10-04
Press Mentions
- URMC to Lead $27M Heart Failure Medication StudyAugust 13th, 2024
- UR Clinical Researchers Get $2.9 Million AwardNovember 15th, 2022
- New DoD Partnership Will Pave the Way for Therapeutic Advances for Chronic DiseasesNovember 2nd, 2022
- Join now to see all
Grant Support
- BCR And Ppargamma As Targets For Transplant ArteriopathyNational Heart, Lung, And Blood Institute2005–2009
- G Proteins As Targets For Transplant ArteriopathyNational Heart, Lung, And Blood Institute1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: